Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 16 | 0 | 0 | 0 | 209 |
| Cost of Goods | 1,553 | -88 | 3 | 0 | 98 |
| Gross Profit | -1,537 | -121 | -3 | 0 | 111 |
| Operating Expenses | 4,755 | 5,420 | 5,713 | 4,778 | 4,069 |
| Operating Income | -5,739 | -5,628 | -5,713 | -4,778 | -3,860 |
| Interest Expense | 249 | 0 | 265 | 284 | 273 |
| Other Income | -467 | 1,921 | 12,938 | -5,072 | -12,917 |
| Pre-tax Income | -6,455 | -3,707 | 6,960 | -10,133 | -17,051 |
| Income Tax | -2,500 | N/A | 0 | 0 | N/A |
| Net Income Continuous | -3,955 | -3,707 | 6,960 | -10,133 | -17,051 |
| Net Income Discontinuous | -7 | -65 | -49 | 32 | -12 |
| Minority Interests | 11 | 4 | N/A | N/A | 20 |
| Net Income | $-3,973 | $-3,776 | $6,911 | $-10,101 | $-17,082 |
| EPS Basic Total Ops | -15.60 | 218.12 | 37.50 | -120.01 | -300.03 |
| EPS Basic Continuous Ops | -25.35 | 219.01 | 37.36 | -120.01 | -300.03 |
| EPS Basic Discontinuous Ops | 9.75 | -0.50 | -0.26 | 0.38 | -0.21 |
| EPS Diluted Total Ops | -15.60 | 288.18 | -33.75 | -120.01 | -300.03 |
| EPS Diluted Continuous Ops | -25.35 | 217.81 | 37.36 | -120.01 | -300.03 |
| EPS Diluted Discontinuous Ops | 9.75 | -0.50 | -0.26 | 0.38 | -0.21 |
| EBITDA(a) | $-5,448 | $-5,338 | $-5,650 | $-4,768 | $-3,858 |